Background {#Sec1}
==========

The burden of Human immunodeficiency virus (HIV) remains one of the most serious public health concerns challenging the world. Worldwide, approximately 37 million people are infected with HIV. In Ethiopia, about 1.2 million people are living with HIV/AIDS and adult HIV prevalence in 2016 was estimated to be 1.1% \[[@CR1], [@CR2]\]. HIV can be transmitted through direct contact with blood, unprotected sexual intercourse with an infected person, use of contaminated needles and syringes, transfusion of infected blood, and mother to child during delivery and others \[[@CR3], [@CR4]\].

Blood transfusion is a routine therapeutic practice which is vital in increasing serum hemoglobin concentration of a patient with anemia and other various medical and surgical conditions. Although blood transfusion can be potentially lifesaving, the risk of several transfusions-transmissible infections such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis is high. Screening of donor blood for transfusion-transmissible infections including HIV is essential for transfusion safety \[[@CR5]--[@CR7]\].

Transfusion of infected blood is one of the foremost causes of morbidity and mortality worldwide, particularly in sub-Saharan Africa, where it is responsible for 5--10% of new HIV infections \[[@CR8]\]. Today, there is an increased need to ensure the safety of all donor blood within 72 h before transfusion \[[@CR9]\]. However, the magnitude of transfusion-associated HIV transmission in sub-Saharan African countries remains high due to reduced financial resources and poor HIV antibody screening programs \[[@CR10]--[@CR12]\].

Maintaining a safe supply of blood for transfusion and blood products for all health facilities is the mission of the National Blood Bank Service of Ethiopia. This is in line to a recommendation from the WHO, which advises that all blood donations should be screened for infections prior to use \[[@CR13]\].

In Ethiopia, several strategies have been implemented to ensure the safety of transfusable blood. Some of the strategies are: improving the operations of the Blood Bank Service, improving access to tools necessary for screening blood and blood products, careful donor selection criteria, safe screening and administration of blood to the recipients, and increasing public awareness on transfusion transmissible infections \[[@CR14]--[@CR17]\]. Although the safety of blood transfusion is maintained in most areas of the country, consistent screening practice is lacking in certain places, increasing the risk of major transfusion-transmissible infections such as HIV \[[@CR18], [@CR19]\].

Monitoring the seroprevalence HIV among blood donors is important for estimating the safety of blood and it is fundamental for developing various safety strategies to minimize infectious diseases transmission \[[@CR7], [@CR20]\]. Studies have been conducted worldwide to determine the prevalence of HIV among blood donors. For instance, seroprevalence of HIV among blood donors is 0.004% in Iran \[[@CR3]\],0.08% in China \[[@CR21]\], 0.07% in Saudi \[[@CR22]\], 0.12% in Nepal \[[@CR23]\], 0.002% in Turkey \[[@CR24]\], 3% in Eastern Sudan \[[@CR25]\], 3.1% in South-west Nigeria \[[@CR26]\], 2.45 in Kenya \[[@CR27]\], and 0.18% in Eritrea \[[@CR28]\].

The few studies conducted in Ethiopia show that HIV infection is highly prevalent among blood donors. However, these findings are mostly inconclusive and inconsistent due to small sample sizes. Due to this, an accurate depiction of the national seroprevalence of HIV in blood donors remains unknown \[[@CR4], [@CR29]\]. Therefore, the objective of this systematic review and meta-analysis is to estimate the pooled seroprevalence of HIV among blood donors in Ethiopia.

Methods {#Sec2}
=======

Study design and literature search {#Sec3}
----------------------------------

Studies on the prevalence of HIV among blood donors published up to 2017 were searched using the following major databases: - PubMed, Cochrane Library, Google Scholar, CINAHL, and EMBASE. We followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines throughout the search \[[@CR30]\]. EndNote version X7 (Thomson Reuters, London) was used to download, organize, review and cite the related articles. To obtain these articles we used the following search terms: "Seroprevalence", "trend", "HIV", "human", "immunodeficiency", "virus", "human immunodeficiency virus", "blood donors", and "blood donors "," Ethiopia". Boolean operators were used to combine search terms during the search as follows: Seroprevalence AND ("HIV"\[MeSH Terms\] OR "HIV" OR "human" AND "immunodeficiency" AND "virus" OR "human immunodeficiency virus" AND "blood donors"\[MeSH Terms\] OR "blood" AND "donors" OR "blood donors" AND "Ethiopia".

Data selection and eligibility {#Sec4}
------------------------------

We included studies that reported the seroprevalence of HIV among blood donors in Ethiopia. Both published and gray literature reported in English language and studies published in the form master's thesis and dissertations were also included. We excluded studies with unspecified sample size, studies that fail to report seroprevalence and studies conducted on the general population.

Data extraction and quality assessment {#Sec5}
--------------------------------------

The eligibility of all relevant articles that were included for full-text review was assessed by two reviewers (HM, GD). Whenever it was necessary, a third reviewer (FW) was consulted. Subsequently, all the selected papers were extracted using pre-piloted data extraction form in Microsoft Excel. The following study characteristics were recorded: author, year of publication, study area, health facility in which the study was conducted, the region of the country the study was conducted, study design, sample size, and the number of seropositive HIV individuals. Finally, all extraction data were checked by two other reviewers (DJ and AN) for accuracy and consistency. Any disagreement and inconsistencies were resolved by discussion and consensus. In this meta-analysis, the methodological and other qualities of the included article were assessed by using a modified version of the Newcastle-Ottawa Scale for cross-sectional studies adopted from PA Modesti et al. \[[@CR31]\].

Statistical analysis {#Sec6}
--------------------

We used a random effects model to generate the overall pooled estimate that is recommended to adjust for variability in the presence of heterogeneity among studies \[[@CR32], [@CR33]\]. This heterogeneity across studies was checked with I^2^ test statistics. Currently, I^2^ test statistics is the preferable and more reliable test in order to measure the variability (Heterogeneity) across the studies. I^2^ ranges between 0 and 100%. An I^2^ less than25% indicates homogeneous whereas I^2^ greater than or equal to 75% indicate very high heterogeneity across studies \[[@CR34]\]. Further, the presence of heterogeneity was assessed by subgroup analysis. Data manipulation and statistical analyses were performed using the Statistical Software Package (STATA) Version 11.0(StataCorp, College Station, TX, USA).

Assessment of publication Bias {#Sec7}
------------------------------

Visual assessment of publication bias was conducted using a funnel plot. Asymmetrical distribution of studies on the funnel plot suggested the presence of publication bias \[[@CR35]\]. Publication bias was also examined with Egger's tests. Additionally, we performed a sensitivity analysis to assess whether the pooled prevalence estimates were influenced by individual studies.

Results {#Sec8}
=======

Search results and selection {#Sec9}
----------------------------

Initially, we identified 1138 studies in the electronic search process. Among these, 13 articles were duplicate and thus removed whereas 1072 were excluded after reviewing titles and abstracts. The full text of the remaining 53 studies was assessed for inclusion based on the predetermined inclusion criteria and 33 of these were excluded because they did not meet the eligibility criteria. Methodological quality assessment based on the Newcastle-Ottawa Scale resulted in the further exclusion of 9 articles. Finally, a total of 11 unique studies were included in the meta-analysis (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Flowchart of study selection for seroprevalence of HIV among blood donors

Characteristics of included studies {#Sec10}
-----------------------------------

This systematic review and meta-analysis conducted up to 2017 included a total of 11 articles with 41, 845 participants in a representative sample from all over Ethiopia. The sample size of the studies ranged from 324 in a study conducted in Felege Hiwot Referral Hospital \[[@CR36]\] to 9384 in Dessie Blood Bank \[[@CR29]\]. Among 11 studies, four were conducted in the Amhara regional state \[[@CR4], [@CR14], [@CR29], [@CR36]\], two in Oromia regional state \[[@CR37], [@CR38]\], three in the South Nations Nationalities and Peoples (SNNP) region \[[@CR18], [@CR39], [@CR40]\], and the remaining were carried out in the Somali region and Addis Ababa \[[@CR41], [@CR42]\]. All articles were cross-sectional studies. Characteristics of the included studies is summarized in Table [1](#Tab1){ref-type="table"}.Table 1Characteristics of included studies for meta-analysis of HIV infection among blood donorsS.NoAuthor/s(reference)Publication YearStudy FacilityStudy area, RegionStudy designSample sizePrevalence %\
(95% CI)1Azene Dessie, et al. \[[@CR36]\]2007Felege Hiwot referral HospitalBahirdar, AmharaCross- sectional32411.7(8.2,15.2)2Bekele Sharew, et al. \[[@CR29]\]2017Dessie Blood BankDessie, AmharaCross- sectional93845.1(4.65,5.55)3Belay Tessema, et al. \[[@CR4]\]2010Gondar University HospitalGonder, AmharaCross- sectional63613.8(3.33,4.27)4Belete Biadgo, et al. \[[@CR14]\]2017Gondar District Blood BankGondar, AmharaCross- sectional64712.24(1.88,2.6)5Melese Gezahegn, et al. \[[@CR37]\]2012Jimma University HospitalJimma, OromiaCross- sectional37881(0.68,1.32)6Ramos, Jose M., et al. \[[@CR38]\]2016Gambo Rural HospitalArsi, OromiaCross- sectional26060.7(0.38,1.02)7Fisseha Bonja, et al. \[[@CR40]\]2017Hawassa Blood BankHawassa, SNNPCross- sectional3841.6(0.35,2.85)8Fithamlak Solomon, et al. \[[@CR39]\]2016Wolaita Sodo University HospitalWolaita, SNNPCross- sectional3906.4(3.97,8.83)9Misganaw Birhaneselassie, et al. \[[@CR18]\]2016Yirgalem Hospital Blood BankYirgalem, SNNPCross- sectional63371.6(1.29,1.91)10Yusuf M. and Alemayehu B. \[[@CR42]\]2016Jijiga Bl ood BankJijiga, SomaliCross- sectional42241.2(0.87,1.53)11Lulseged Assefa \[[@CR41]\]2017National Blood BankAddis AbebaCross- sectional15761.1(0.59,1.61)

Prevalence of HIV infection among blood donors in Ethiopia (the result of meta-analysis) {#Sec11}
----------------------------------------------------------------------------------------

The meta-analysis found significant heterogeneity across studies (I^2^ = 97.6%, *p* \< 0.001), indicating that the fixed effect model may lead to an unreliable estimate. As a result, we used the random effects model to estimate the pooled seroprevalence of HIV among blood donors. The overall pooled prevalence of HIV reported by the 11 studies using the random effects model was 2.69% (95% CI: 1.79--3.58%). The pooled prevalence of HIV is presented in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Forest plot showing the pooled seroprevalence of HIV among blood donors

In addition, we conducted sub-group analysis by region to minimize the potential random variations between studies by HIV seroprevalence among blood donors. The analysis found the highest estimated seroprevalence among blood donors among studies conducted in Amhara region (4.78, 95% CI: 3.04, 6.52%, I^2^ = 0.001). The subgroup analysis is presented in Fig. [3](#Fig3){ref-type="fig"}.Fig. 3Subgroup analysis by regions on the seroprevalence of HIV among blood donors

Publication Bias assessment {#Sec12}
---------------------------

Presence of publication bias was examined using a funnel plot and Egger's test. Visual inspection of the funnel plot suggested asymmetry (Fig. [4](#Fig4){ref-type="fig"}). However, asymmetry of the funnel plot was not statistically significant as evidenced by Egger's test (*P* = 0.31). Asymmetry in the funnel plots should not be always linked with publications bias \[[@CR35]\]. High heterogeneity between the studies might be the reason for the asymmetry of the funnel plot in this systematic review and meta-analysis. Additionally, the result of sensitivity analyses using random effects model suggested that no single study unduly influenced the overall estimate (Fig. [5](#Fig5){ref-type="fig"}).Fig. 4Funnel plot to test the publication bias in the 11 studiesFig. 5Result of sensitivity analysis of the 11 studies

Trend of HIV Seroprevalence among blood donors {#Sec13}
----------------------------------------------

Studies were divided into four groups according to the study period in order to observe the trend of HIV seroprevalence (Table [2](#Tab2){ref-type="table"}). Our systematic review and meta-analysis showed that the seroprevalence of HIV among blood donors in Ethiopia has dramatically declined from 2004 to 2016. The seroprevalence of HIV was 4.69% between 2004 and 2006 and then decreased radically to 1.03% from 2013 to 2016. The trend of HIV prevalence among blood donors in Ethiopia is summarized in Fig. [6](#Fig6){ref-type="fig"}.Table 2Trend of HIV seroprevalence among blood donors in Ethiopia from 2004 to 2016Study periodPrevalence of HIV\
% (95%CI)HeterogeneityI^2^*P* value2004--20064.69(3.31,6.08)83.30.0012007--20093.16(1.47,4.84)95.20.0012010--20121.97(1.32,2.62)97.10.0012013--20161.03(0.35,1.71)89.20.001Fig. 6Trend of HIV prevalence among blood donors in Ethiopia from 2004 to 2016

Distribution by gender and age group {#Sec14}
------------------------------------

Nine studies have tested the association between seroprevalence of HIV and sex of blood donors. The seroprevalence of HIV among male blood donors was 2.33(95%CI: 1.17, 3.48) and 2.65 (95%CI: 1.26--4.04) among female blood donors. However, there was no statistically significant difference in HIV seropositivity between male and female donors (*P* = 0.07). Additional three studies with similar age groups were investigated:-. HIV prevalence rate was 1.91% (95% CI: 0.17, 3.99) among blood donors aged 18--35), 2.86% (95% CI: 0.07--5.66) among blood donors aged 36--45, and 3.32% (95% CI: 2.16--4.48) among donors aged 45 or older.

Discussion {#Sec15}
==========

Blood safety remains a major challenge in Africa, especially in Sub-Saharan countries \[[@CR13]\]. Screening of blood has important public health benefits for the recipient and the community. Screening is also important for early prevention, diagnosis, and treatment of TTIs. The results of this study showed that the pooled prevalence of HIV infection among blood donors in studies spanning more than 12 years was 2.69% (95% CI (1.79--3.58%)). The prevalence of HIV infection found in this study is consistent with findings from similar ones conducted in different countries \[[@CR7], [@CR25]--[@CR27]\]. Moreover, the seroprevalence of HIV among blood donors was unevenly distributed across the regions of the country, with the highest prevalence rate of HIV observed in Amhara regional state. This could be due to the fact that HIV incidence in the general population of Amhara region is high as compared to the other regions \[[@CR43]\].

The WHO has estimated the prevalence of HIV in blood donors of low-income countries to be in the range of 0.56 to2.69% \[[@CR13]\], which is comparable with our result. However, the overall estimate of HIV infection among blood donors in this study (2.69%) is higher than other similar studies \[[@CR3], [@CR21]--[@CR24], [@CR28], [@CR44]\]. This higher prevalence rate might be attributable to low public awareness regarding HIV along with the higher incidence rate of HIV infection in the general population \[[@CR45]--[@CR47]\]. In contrast, studies conducted in some African countries such as in Equatorial Guinea, Nigeria, Ghana, and Tanzania showed the seroprevalence of HIV among blood donors was 7.83% \[[@CR48]\], 4.2% \[[@CR49]\], 4.06% \[[@CR50]\], and 3.8% \[[@CR51]\] respectively. These variations might be due to the difference in the eligibility criteria for blood donation, the type of donors and the effectiveness of the selection procedure.

Even though the incidence and the prevalence of HIV infection shows a rising pattern in the general population of the country in the last few years, the prevalence of HIV among blood donors in Ethiopia has declined from 2004 to 2016 (Fig. [6](#Fig6){ref-type="fig"}). Similar declining pattern has been reported among blood donors in United States \[[@CR52]\], Iran \[[@CR3]\] and Saudi Arabia \[[@CR22]\]. The possible reason for this drastically declining trend in HIV seroprevalence throughout Ethiopia after 2004 might be the implementation of effective infection control measures such as the presence of highly qualified human resource, regular supply of reagents, and improved sensitivity of reagents used in blood screening tests in recent years \[[@CR15]\]. However, global trends are not always decreasing as seen in China, where increasing HIV seroprevalence is reported \[[@CR21]\], and in Ghana where seroprevalence of HIV infection among blood donors has remained steady \[[@CR50]\].

Our findings also revealed that the seroprevalence of HIV was higher among female donors as compared to male donors. Other similar studies showed similar observation \[[@CR21], [@CR27], [@CR49]\]. This could be due to the fact that females are more vulnerable in the general population than males for HIV infection due to different socioeconomic, cultural, and biological factors \[[@CR53]\]. However, our findings are also contrary to other studies where the seroprevalence of HIV infection was higher among male donors than females \[[@CR3], [@CR23], [@CR52], [@CR54]\] or the same across the sexes \[[@CR7]\].

This systematic review and meta-analysis also showed that the highest HIV seropositivity was detected on donors older than 45 years. This finding is in agreement with previous similar African studies reports \[[@CR7], [@CR48], [@CR50]\]. This might be due to differences in risk behaviors among different age groups. Additional factors explaining the difference in age can be being away from home due to a job, increasing the risk of sexual contact. However, this finding was not in line with studies done in Nigeria \[[@CR26]\] and Nepal \[[@CR23]\] where a higher HIV seroprevalence rate was detected in younger age groups: 18--27 and 21--30 years respectively.

Although blood donors may not reflect the general population, this meta-analysis has provided valuable information regarding the seroprevalence of HIV among blood donors. However, there were some limitations that could be addressed in future systematic reviews and meta-analyses. The major limitation of this study is the lack of other published systematic reviews and meta-analyses on the seroprevalence of HIV among blood donors for comparison. Besides, because of the lack of similar variables in the selected articles, we were unable to analyze risk factors that can potentially explain the observed relationships.

The findings of this study have implication for clinical practice. Determining the seroprevalence of HIV among blood donors is critical to ensure the safety of blood transfusion. Therefore, ensuring the provision of safe blood transfusion requires effective legislative policies and strategies.

Conclusion {#Sec16}
==========

This systematic review and meta-analysis show a high seroprevalence of HIV infection among Ethiopian blood donors. Hence, strict selections of blood donors with a standard clinical diagnosis and screening methods are highly recommended to ensure the safety of transfusable blood. However, this seroprevalence of HIV among blood donors is showing a declining trend across the years (2004 to 2016) in Ethiopia. HIV seropositivity is highly prevalent among females and on donors older than 45 years of age. Therefore, Ethiopian health authorities (e.g. Federal Ministry of Health) should strengthen the existing declining trend and design interventions to increase awareness among the aforementioned groups. Future large scale research is necessary to identify possible risk factors associated with HIV infection among blood donors.
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